Suppr超能文献

相似文献

1
causalCmprsk: An R package for nonparametric and Cox-based estimation of average treatment effects in competing risks data.
Comput Methods Programs Biomed. 2023 Dec;242:107819. doi: 10.1016/j.cmpb.2023.107819. Epub 2023 Sep 21.
2
Semiparametric competing risks regression under interval censoring using the R package intccr.
Comput Methods Programs Biomed. 2019 May;173:167-176. doi: 10.1016/j.cmpb.2019.03.002. Epub 2019 Mar 8.
3
Competing risks analysis with missing cause-of-failure-penalized likelihood estimation of cause-specific Cox models.
Stat Methods Med Res. 2022 May;31(5):978-994. doi: 10.1177/09622802211070254. Epub 2022 Jan 17.
7
Flexible parametric modelling of the cause-specific cumulative incidence function.
Stat Med. 2017 Apr 30;36(9):1429-1446. doi: 10.1002/sim.7208. Epub 2016 Dec 22.
8
Modelling two cause-specific hazards of competing risks in one cumulative proportional odds model?
Stat Med. 2017 Nov 30;36(27):4353-4363. doi: 10.1002/sim.7437. Epub 2017 Aug 22.
9
SemiCompRisks: An R Package for the Analysis of Independent and Cluster-correlated Semi-competing Risks Data.
R J. 2019 Jun;11(1):376-400. doi: 10.32614/rj-2019-038. Epub 2019 Aug 20.
10
Modeling time-varying exposure using inverse probability of treatment weights.
Biom J. 2018 Mar;60(2):323-332. doi: 10.1002/bimj.201600223. Epub 2017 Dec 27.

引用本文的文献

2
Impact of Severe COVID-19 on Accelerating Dementia Onset: Clinical and Epidemiological Insights.
medRxiv. 2025 Mar 28:2025.03.26.25324688. doi: 10.1101/2025.03.26.25324688.
3
Assessing treatment effects with adjusted restricted mean time lost in observational competing risks data.
BMC Med Res Methodol. 2024 Aug 26;24(1):186. doi: 10.1186/s12874-024-02303-5.
4
Association of BCG Vaccine Treatment With Death and Dementia in Patients With Non-Muscle-Invasive Bladder Cancer.
JAMA Netw Open. 2023 May 1;6(5):e2314336. doi: 10.1001/jamanetworkopen.2023.14336.
6
Prolonged Intubation in Patients With Prior Cerebrovascular Disease and COVID-19.
Front Neurol. 2021 Apr 9;12:642912. doi: 10.3389/fneur.2021.642912. eCollection 2021.
7
Electroencephalographic Abnormalities are Common in COVID-19 and are Associated with Outcomes.
Ann Neurol. 2021 May;89(5):872-883. doi: 10.1002/ana.26060. Epub 2021 Mar 24.

本文引用的文献

3
Inflammatory Diseases, Inflammatory Biomarkers, and Alzheimer Disease: An Observational Analysis and Mendelian Randomization.
Neurology. 2023 Feb 7;100(6):e568-e581. doi: 10.1212/WNL.0000000000201489. Epub 2022 Nov 16.
4
Doubly-robust estimator of the difference in restricted mean times lost with competing risks data.
Stat Methods Med Res. 2022 Oct;31(10):1881-1903. doi: 10.1177/09622802221102625. Epub 2022 May 23.
5
Causal inference for semi-competing risks data.
Biostatistics. 2022 Oct 14;23(4):1115-1132. doi: 10.1093/biostatistics/kxab049.
7
Prolonged Intubation in Patients With Prior Cerebrovascular Disease and COVID-19.
Front Neurol. 2021 Apr 9;12:642912. doi: 10.3389/fneur.2021.642912. eCollection 2021.
8
Electroencephalographic Abnormalities are Common in COVID-19 and are Associated with Outcomes.
Ann Neurol. 2021 May;89(5):872-883. doi: 10.1002/ana.26060. Epub 2021 Mar 24.
9
gfoRmula: An R Package for Estimating the Effects of Sustained Treatment Strategies via the Parametric g-formula.
Patterns (N Y). 2020 Jun 12;1(3). doi: 10.1016/j.patter.2020.100008. Epub 2020 May 18.
10
How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19.
Ann Intern Med. 2020 Oct 20;173(8):632-637. doi: 10.7326/M20-4044. Epub 2020 Jul 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验